Paolo Marchetti

Pubblicazioni

Titolo Pubblicato in Anno
Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence JOURNAL OF CELLULAR PHYSIOLOGY 2020
Exploring the molecular insights of concurrent composite mucoepidermoid carcinoma and papillary thyroid carcinoma ENDOCRINE 2020
Correction to. Exploring the molecular insights of concurrent composite mucoepidermoid carcinoma and papillary thyroid carcinoma ENDOCRINE 2020
5-Fluorouracil degradation rate as a predictive biomarker of toxicity in breast cancer patients treated with capecitabine JOURNAL OF ONCOLOGY PHARMACY PRACTICE 2020
Is there a place for crizotinib in c-MET alterations? A case of efficacy in ALK positive NSCLC patient with secondary c-MET amplification ANNALS OF ONCOLOGY 2020
The impact of locoregional treatment on response to Nivolumab in advanced platinum refractory head and neck cancer: the NEED TRIAL VACCINES 2020
The agnostic role of site of metastasis in predicting outcomes in cancer patients treated with immunotherapy VACCINES 2020
The Exponential Phase of the Covid-19 Pandemic in Central Italy: An Integrated Care Pathway INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 2020
Tobacco, alcohol and family history of cancer as risk factors of oral squamous cell carcinoma: case-control retrospective study APPLIED SCIENCES 2020
Radiopharmaceuticals for breast cancer and neuroendocrine tumor. Two examples of how tissue characterization may influence the choice of therapy CANCERS 2020
Late immune-related adverse events in long-term responders to PD-1/PD-L1 checkpoint inhibitors: A multicentre study EUROPEAN JOURNAL OF CANCER 2020
The treatment paradigm of right-sided metastatic colon cancer: harboring BRAF mutation makes the difference INTERNATIONAL JOURNAL OF COLORECTAL DISEASE 2020
The 5-Ws of immunotherapy in head and neck cancer CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY 2020
Tryptophan Catabolism as Immune Mechanism of Primary Resistance to Anti-PD-1 FRONTIERS IN IMMUNOLOGY 2020
Exploratory pilot study of circulating biomarkers in metastatic renal cell carcinoma CANCERS 2020
Induction chemotherapy in nonlaryngeal human papilloma virus-negative high-risk head and neck cancer: a real-world experience ANTI-CANCER DRUGS 2020
Phase 2 of coronavirus disease (COVID-19) and head and neck cancer: an action plan ORAL DISEASES 2020
Tissue immune profile: a tool to predict response to neoadjuvant therapy in triple negative breast cancer CANCERS 2020
Efficacy of immunotherapy in lung cancer with co-occurring mutations in NOTCH and homologous repair genes JOURNAL FOR IMMUNOTHERAPY OF CANCER 2020
Combination therapy of high-dose rabeprazole plus metronomic capecitabine in advanced gastrointestinal cancer: a randomized phase II trial CANCERS 2020

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma